ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 194 filers reported holding ARRAY BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $26,600,000 | +98418.5% | 574,144 | +29694.7% | 1.31% | +65350.0% |
| Q4 2018 | $27,000 | -75.5% | 1,927 | -73.3% | 0.00% | -66.7% |
| Q3 2018 | $110,000 | +86.4% | 7,208 | +105.1% | 0.01% | +50.0% |
| Q2 2018 | $59,000 | -92.2% | 3,515 | -92.4% | 0.00% | -92.7% |
| Q1 2018 | $755,000 | +57.3% | 46,252 | +23.4% | 0.06% | +41.0% |
| Q4 2017 | $480,000 | +879.6% | 37,494 | +842.8% | 0.04% | +875.0% |
| Q3 2017 | $49,000 | +81.5% | 3,977 | +21.4% | 0.00% | +33.3% |
| Q2 2017 | $27,000 | -70.0% | 3,276 | -87.0% | 0.00% | -76.9% |
| Q2 2016 | $90,000 | +136.8% | 25,200 | +93.8% | 0.01% | +160.0% |
| Q1 2016 | $38,000 | -24.0% | 13,000 | +10.2% | 0.01% | -37.5% |
| Q4 2015 | $50,000 | +316.7% | 11,800 | +637.5% | 0.01% | +300.0% |
| Q2 2015 | $12,000 | -62.5% | 1,600 | -63.6% | 0.00% | -50.0% |
| Q1 2015 | $32,000 | -76.8% | 4,400 | -85.4% | 0.00% | -77.8% |
| Q2 2014 | $138,000 | +187.5% | 30,200 | +193.2% | 0.02% | +200.0% |
| Q1 2014 | $48,000 | – | 10,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |